March 3, 2019 · Cancer, Doctor · (No comments)

Erick Lesfkofsky is an American billionaire who co-founded Tempus. He is also the current CEO of Tempus. He was raised in a Jewish family and attended the University of Michigan where he graduated with honors. To further the studies he went to University of Michigan Law School where he graduated in 1993.

Erick Lesfkofsky also participates in philanthropic activities. Together with his wife, Liz they established Lesfkofsky family foundation in 2006. It is a private charity organization that strives to improve the lives of children through high impact initiatives. Since its formation, it has funded more than fifty organizations.

Erick is also concerned about the interests of the community, and this had made him serve on different boards that are community oriented. He serves in many boards of directors including the children memorial hospital and the world business Chicago.

Erick Lesfkofsky is also a professor at the University of Chicago. He is also the author of Accelerated Disruption: Understanding the True Speed of Innovation. In his book, he talks about how great business ideas are born in people’s minds, but people end up not working on their plans.

According to Erick Lesfkofsky, this is because they fail to realize how they can use technology to bring their ideas to life. His book describes how business can use technology advancements to survive and thrive in a competitive business environment. The book also explains the trends that make many companies decline.

Tempus is a technology company that enables doctors to give cancer patients personalized care by using interactive analytical and machine learning platform. According to Erick, he got the idea to start the company when he witnessed the treatment process of a family member.

The process made him search for a way to use technology to help in the fight against cancer. Tempus strives at fighting cancer by equipping doctors all the knowledge they need using molecular and clinical data. According to Erick Lesfkofsky, the future of less cancer diagnosis lies in data-driven health care. He also stated that Tempus was concentrating its time and resources in data collection.

About Eric Lefkofsky:

March 7, 2018 · Cancer, Cancer Research · (No comments)

Lots of people who eventually find out that they have cancer are surprised as they were oblivious to the known signs and basic symptoms. CTCA and WebMD are now confronting the widespread ignorance of cancer that is a huge problem in the world today. When someone doesn’t know something crucial regarding their health, they could end up suffering much more than they needed to. Cancer Treatment Centers of America have always been willing to share any of their cancer knowledge both to other medical professionals and cancer care providers and to the many individuals that have turned to them for help.

CTCA hopes to educate everyone on various cancer information. Their biggest goal is to cut down and hopefully someday stop death from occurring just because someone didn’t know how serious their symptoms were. By giving out more cancer details over the Internet, CTCA is targeting a new people group. WebMD is often the site that many familiar with the Internet individuals turn to with health related questions. These Internet browsers have come to trust this healthcare site to give highly researched information. Other Internet sites don’t follow these stricter guidelines before they print an article. CTCA and WebMD combined their resources to bring new cancer healthcare information for online users to easily read. Often, patients that come to Cancer Treatment Centers of America will complain that they didn’t really understand what their healthcare providers were telling them. Sometimes cancer and other healthcare related information is spoken as healthcare providers are used to hearing it.

The problem with this format is that everyday individuals not familiar with healthcare lingo often cannot receive the understanding of spoken information. This is a huge reason whey CTCA have recently joined together with WebMD so the highly complex and confusing medical jargon could be broken down into everyday language that most anyone can understand. Cancer Treatment Centers of America has been in the cancer care business for decades. Their full commitment to all of their patients is very evident in the way that care is done at the five CTCA facilities. Many are relieved when they realize how caring and compassionate the healthcare providers and many supportive staff are to each of their patients. The holistic care approach coined by CTCA is able to treat the entire person rather than just the cancer. This impresses patients greatly, and the methodology does seem to work.

December 15, 2017 · Cancer, Cancer Research · (No comments)

The cancer menace affects a lot of people across the world. The disease has caused pain and affliction to lot families across the globe. In America alone, at least 40 percent of adults are diagnosed with cancer at some point in their lives. National Cancer Institute revealed that close to 15 million people in the U.S. were diagnosed with cancer in 2014. The figures are expected to shoot to close to 20 million in the coming ten years. These figures can, however, come down if there is adequate information on specific treatment options for cancer in our hospitals. Lack of adequate information is one of the hindrances to the treatment of cancer.

Cancer Centers of America are one of the organizations that have put a spirited fight against cancer. The organization, through their affiliate hospitals, has teamed up with Nanthealth and Allscripts to roll out a new program that will enable quick access to critical information needed during the cancer treatment process.The new platform created by the three organizations will allow clinicians and researchers to access a pool of cancer care data. The database will continuously be updated by oncologists and physicians who have experience and expertise in dealing with different types of cancer. The critical information in the database can be accessed within a few clicks.

The three organizations launched the partnership in 2016 as they tried to brainstorm on how they can deliver better services to the cancer patients. The new platform is known as clinical pathways, and it will allow the eviti system by Nanthealth to access the Allscripts Sunrise EHR.The Allscripts Sunrise EHR contains more than 2700 evidence-based treatments which allow clinicians and oncologists to weigh on different treatment possibilities that they can recommend to their patients. The integrity of the clinical pathways program is assured since it is maintained by highly experienced oncologists and researchers in America.Through the clinical pathways platform, oncologists can create customized treatment plans with the input from the patients. The platform also helps them to compare treatment options and costs, and also examine other complimentary services that a cancer patient would consider.